Literature DB >> 3394658

Agarose gel patterns of alkaline phosphatase isoenzymes before and after treatment with neuraminidase.

W E Schreiber1, L C Sadro.   

Abstract

The clinical value of alkaline phosphatase isoenzyme analysis is limited by the inability of most electrophoretic methods to resolve the liver and bone isoenzymes. The authors attacked this problem by treating serum samples with neuraminidase, then running treated and untreated samples side-by-side on specially prepared agarose gels. Each isoenzyme showed a characteristic mobility before and after neuraminidase treatment that allowed its identification. The mobility of the bone isoenzyme was most affected, whereas the intestinal isoenzyme was resistant to the action of neuraminidase. In samples with both liver and bone isoenzymes, pretreatment with neuraminidase clearly distinguished the bands, allowing quantitation by densitometry. Using this method, the authors discovered 22 liver isoenzymes in 54 samples that were interpreted as only bone isoenzyme before neuraminidase treatment. They also detected two bone isoenzymes in 35 samples that appeared to contain only liver +/- biliary isoenzymes. In addition, this procedure enabled them to characterize several unusual isoenzymes with respect to mobility, thus avoiding confusion with the other isoenzymes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3394658     DOI: 10.1093/ajcp/90.2.181

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Detection of bone-type alkaline phosphatase by monoclonal antibodies reacting with human osteosarcoma-associated antigen.

Authors:  S Nagoya; T Uede; T Wada; S Ishii; S Yamawaki; K Kikuchi
Journal:  Jpn J Cancer Res       Date:  1991-07

2.  Anthropometric and blood data on a hand-reared captive Asian elephant (Elephas maximus) calf: A retrospective case report.

Authors:  Kazuya Takehana; Ryohei Kitani; Kaoru Hatate; Rurika Onomi; Norio Yamagishi
Journal:  J Vet Med Sci       Date:  2020-05-21       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.